Marshall Wace North America’s KalVista Pharmaceuticals KALV Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-22,136	Closed	-$530K	–	1525
2021 Q2	$530K	Sell	22,136 -76,042	-77%	-$1.82M	﹤0.01%	1117
2021 Q1	$2.52M	Buy	+98,178	New	+$2.52M	0.01%	745
2019 Q2	–	Sell	-6,126	Closed	-$175K	–	1368
2019 Q1	$175K	Buy	+6,126	New	+$175K	﹤0.01%	1016